Sebia Overview

  • Year Founded
  • 1967

Year Founded

  • Status
  • Private

  • Employees
  • 1,300

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 15

  • Investments
  • 2

Sebia General Information

Description

Manufacturer of in vitro diagnostic equipment and reagents intended for disease screening and monitoring. The company specializes in capillary electrophoresis and other separation techniques to analyze protein modifications, enabling accurate diagnosis and management of chronic, metabolic and rare diseases.

Contact Information

Website
www.sebia.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Parc Technologique Léonard de Vinci
  • CP 8010
  • 91008 Lisses
  • France
+33 01
Primary Industry
Diagnostic Equipment
Vertical(s)
Manufacturing
Corporate Office
  • Parc Technologique Léonard de Vinci
  • CP 8010
  • 91008 Lisses
  • France
+33 01

Sebia Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sebia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sebia‘s full profile, request access.

Request a free trial

Sebia Patents

  • 232

    Total Documents Applications and Grants

  • Total Patents Families

  • 75

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Sebia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2805740-T3 Electrophoresis method with immunofixation with gel immuno-displacement of target components Active 27-Jul-2016
EP-3276351-A1 Immunofixation electrophoresis method with target component on-gel immunodisplacement Active 27-Jul-2016
EP-3276351-B1 Immunofixation electrophoresis method with target component on-gel immunodisplacement Active 27-Jul-2016
US-12306183-B2 Immunofixation electrophoresis method with target component on-gel immunodisplacement Active 27-Jul-2016
CA-3031595-A1 Improved immunofixation electrophoresis method with target component on-gel immunodisplacement Active 27-Jul-2016 G01N33/561
To view Sebia’s complete patent history, request access »

Sebia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sebia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sebia‘s full profile, request access.

Request a free trial

Sebia Investments (2)

Sebia’s most recent deal was a Buyout/LBO with Zeus Scientific. The deal was made on 11-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zeus Scientific 11-Oct-2022 Buyout/LBO Diagnostic Equipment
Orgentec Diagnostika 08-Sep-2021 Buyout/LBO Diagnostic Equipment
To view Sebia’s complete investments history, request access »

Sebia Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Sebia Sweden Solna, Sweden 2023
Sebia Benelux Vilvoorde, Belgium 1995
Orgentec Diagnostika Mainz, Germany 1988
Zeus Scientific Branchburg, NJ 1976

Sebia FAQs

  • When was Sebia founded?

    Sebia was founded in 1967.

  • Where is Sebia headquartered?

    Sebia is headquartered in Lisses, France.

  • What is the size of Sebia?

    Sebia has 1,300 total employees.

  • What industry is Sebia in?

    Sebia’s primary industry is Diagnostic Equipment.

  • Is Sebia a private or public company?

    Sebia is a Private company.

  • What is the current valuation of Sebia?

    The current valuation of Sebia is .

  • What is Sebia’s current revenue?

    The current revenue for Sebia is .

  • How much funding has Sebia raised over time?

    Sebia has raised $348M.

  • Who are Sebia’s investors?

    Warburg Pincus, CVC Capital Partners, La Caisse, and Tethys Investments have invested in Sebia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process